| Institution: | 1. School of Engineering and Informatics, University of Sussex, Falmer, Brighton, BN1 9QJ, United Kingdom;2. MRC Brain Network Dynamics Unit, University of Oxford, Oxford, OX1 3TH, United Kingdom;3. Sackler Center for Consciousness Science, University of Sussex, Falmer, Brighton, BN1 9QJ, United Kingdom;1. Faculty of Pharmacy, Helwan University, Cairo, Egypt, Saudi Arabia;2. College of Clinical Pharmacy, King-Faisal University, Al Ahsa, Saudi Arabia;3. Al Ahli hospital, Doha, Qatar;4. Faculty of Medicine, Zagazig University, Zagazig, Egypt, USA;5. Department of Medical Microbiology and Immunology, School of Medicine, Creighton University, Omaha, NE, USA;1. Department of Medical Physics, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK;2. Metrology for Medical Physics Centre, National Physical Laboratory, Teddington, UK;3. European Organization for Research and Treatment of Cancer (EORTC) Headquarters, Belgium;4. Mount Vernon Cancer Centre, Northwood, UK;5. Radiotherapy Trials QA (RTTQA), UK;6. Calvary Mater Hospital and University of Newcastle, Australia;7. Trans-Tasman Radiation Oncology Group (TROG), Australia;8. School of Physics, University of Sydney, Camperdown, Australia;9. Department of Radiology, Graduate School of Medical Sciences, Nagoya City University, Japan;10. Japan Clinical Oncology Group (JCOG), Japan;11. Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, USA;12. Imaging and Radiation Oncology Core (IROC), USA;13. Australian Clinical Dosimetry Service (ACDS), Australia;14. Department of Medical Physics, Niguarda Hospital, Milan, Italy;15. Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Japan;p. Catharina Hospital, Eindhoven, The Netherlands |
